These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10989630)

  • 1. [Recommendations from the experimental sites for implementing organized cervical cancer screening in France].
    Baudier F; Schapman S; Giordanella JP
    Sante Publique; 2000 May; 12 Spec No():71-88. PubMed ID: 10989630
    [No Abstract]   [Full Text] [Related]  

  • 2. [Creating favorable conditions for organized screening of cervical cancer].
    Baudier F
    Sante Publique; 2000 May; 12 Spec No():5-10. PubMed ID: 10989624
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cervical cancer screening in the Bas-Rhin. Evaluation of four and a half years of the EVE campaign].
    Fender M; Schaffer P; Dellenbach P
    Sante Publique; 2000 May; 12 Spec No():11-20. PubMed ID: 10989625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Re: the editorial in number 4, volume 28, 2008. "Cervical cancer control in Colombia: achievements and challenges of cytology based programs"].
    Calvache AE
    Biomedica; 2009 Mar; 29(1):161-2; author reply 162-3. PubMed ID: 19753849
    [No Abstract]   [Full Text] [Related]  

  • 5. [Guidelines for the evaluation of internal quality control of smears for screening of uterine cancer in France in the structures of Pathologic Anatomy and Cytology. French Association for Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP)--Commission for cervical smears].
    Albuisson F; Anger E; Baron V; Cartier I; Dorne H; Dubois-Gordeff A; Hassoun J; Jouannelle A; Labbé S; Locquet D; Marsan C; Martin E; Michiels-Marzias D; Molinié V; Mottot C; Mueller B; Vacher-Lavenu MC; Vincent S; Vuong PN
    Ann Pathol; 1998 Jul; 18(3):221-6. PubMed ID: 9750045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality control in cytopathology applied to screening for cervical carcinoma.
    Marsan C
    Pol J Pathol; 1995; 46(4):245-8. PubMed ID: 8713292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care practice and facility quality orientation: influence on breast and cervical cancer screening rates.
    Goldzweig CL; Parkerton PH; Washington DL; Lanto AB; Yano EM
    Am J Manag Care; 2004 Apr; 10(4):265-72. PubMed ID: 15124503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The "Action Woman Health" program in three Lyons suburbs].
    Mignotte H; Le Goaziou MF; Nachury LP; Pérol D; Fontaniere B; Fouillat V; Lasset C
    Sante Publique; 2000 May; 12 Spec No():45-58. PubMed ID: 10989628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cervical cancer screening campaign in Doubs: evaluation of the first three years of the pilot program].
    Gautier CP; Monnet E; Meslans Y
    Sante Publique; 2000 May; 12 Spec No():37-43. PubMed ID: 10989627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for cervical cancer. Canadian programmatic guidelines.
    Parboosingh J
    Can Fam Physician; 1999 Feb; 45():383-93. PubMed ID: 10065312
    [No Abstract]   [Full Text] [Related]  

  • 11. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.
    Coleman D; Day N; Douglas G; Farmery E; Lynge E; Philip J; Segnan N
    Eur J Cancer; 1993; 29A Suppl 4():S1-38. PubMed ID: 8274301
    [No Abstract]   [Full Text] [Related]  

  • 12. [Personnel training for a population screening program for cervical carcinoma].
    Branca M; Rossi E; Cedri C; Migliore G; Cedri S; Aldovini A; Leoncini L; Bonelli L; Montanari G; Navone R
    Pathologica; 2001 Jun; 93(3):233-41. PubMed ID: 11433619
    [No Abstract]   [Full Text] [Related]  

  • 13. Cervical cancer prevention for all Canadians.
    Sellors JW
    Can Fam Physician; 1999 Feb; 45():245-7, 252-4. PubMed ID: 10065291
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of a cervical cancer screening campaign: reflections on the experience in Martinique].
    Briollais L; Feyler A; Ossondo M; Dorival MJ; Le Mab G; Escarmant P; Azaloux H
    Sante Publique; 2000 May; 12 Spec No():21-35. PubMed ID: 10989626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast and cervical cancer screening: clinicians' views on health plan guidelines and implementation efforts.
    Zapka JG; Puleo E; Taplin S; Solberg LI; Mouchawar J; Somkin C; Geiger AM; Ulcickas Yood M
    J Natl Cancer Inst Monogr; 2005; (35):46-54. PubMed ID: 16287885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An operative model: verification of the quality of the screening Pap test ].
    Montanari GR; Arnaud S; Berardengo E; Campione D; Cozzani C; Parisio F; Viberti L; Ghiringhello B
    Pathologica; 2001 Oct; 93(5):609-10. PubMed ID: 11725370
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges to cervical cancer screening in the Western Cape province.
    Smith N; Moodley J; Hoffman M
    S Afr Med J; 2003 Jan; 93(1):32-5. PubMed ID: 12564327
    [No Abstract]   [Full Text] [Related]  

  • 18. Cervical cancer: an overview with suggested practice and policy goals.
    Wells SF
    Medsurg Nurs; 2008 Feb; 17(1):43-50; quiz 51. PubMed ID: 18429541
    [No Abstract]   [Full Text] [Related]  

  • 19. Quality assessment in the age of machine-aided cervical cytology screening.
    Renshaw AA
    Cancer; 2004 Dec; 102(6):345-7. PubMed ID: 15540251
    [No Abstract]   [Full Text] [Related]  

  • 20. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology.
    Herbert A; Bergeron C; Wiener H; Schenck U; Klinkhamer P; Bulten J; Arbyn M
    Cytopathology; 2007 Aug; 18(4):213-9. PubMed ID: 17635161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.